Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal.

Abstract

Agomelatine is the first approved antidepressant that mediates its activity through the melatoninergic pathway rather than the monoaminergic system. This meta-analysis aims to summarize an up-to-date report on the efficacy of agomelatine in major depressive disorder. Archives of published results in PubMed, CINAHL, Cochrane Library, EMBASE and PsycINFO… (More)
DOI: 10.1017/S1461145711001301

Topics

6 Figures and Tables

Cite this paper

@article{Singh2012EfficacyOA, title={Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal.}, author={Surendra Pal Singh and Vidhi Singh and Nilamadhab Kar}, journal={The international journal of neuropsychopharmacology}, year={2012}, volume={15 3}, pages={417-28} }